Skip to main content
Young Hong, MD, Oncology, Camden, NJ

Young Ki Hong MD ,MPH, FACS, FSSO

Oncology•Camden, NJ

Gastrointestinal Cancer, Melanoma

Chief, Division of Surgical Oncology and Hepatobiliary, Director of Clinical Research and Cellular Therapy, Director of Peritoneal Surface Malignancy Program

Join to View Full Profile

  • Cooper University HospitalThree Cooper Plaza, Suite 411Camden, NJ 08103

  • Phone+1 856-968-7014

  • Fax+1 856-968-7015

Dr. Hong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Hong's Full ProfileAlready have an account?

Summary

  • Dr. Young Hong is an oncology specialist based in Camden, NJ, with subspecialties in gastrointestinal cancer and melanoma. His educational background includes multiple fellowships at the University of Louisville and the Clinical Center at the National Institutes of Health, and he holds an MPH in Health Policy. Dr. Hong currently holds several leadership roles at Cooper University Healthcare, including Director of the Peritoneal Surface Malignancy Program and Chief of the Division of Surgical Oncology. He has extensive experience in cholangiocarcinoma, pancreaticoduodenectomy, cutaneous melanoma, and tumor immunotherapy. His research contributions include publications on DNA methyltransferase and immune modulation in cancer. He has been involved in clinical trials related to tumor-infiltrating lymphocytes and has received honors, including the NJ Biz Healthcare Heroes Innovation Hero award.

    • MD Anderson Cancer Center at Cooper offers noninvasive histotripsy for treating

    Surgical oncologists at MD Anderson Cancer Center at Cooper in Camden used histotripsy, an innovative noninvasive technology that uses sound waves to destroy ca

    TIL, then: Why Cooper doctor is excited to bring novel melanoma treatment to Sou

    If surgical oncologist Dr. Young K. Hong had a guess - maybe a hope - where medicine is headed: It's toward every patient having treatment that's totally indivi

    Clinical trial treats patients with advanced melanoma

    Dr. Young Ki Hong from MD Anderson Cancer Center and patient Debra Marsdale join Good Day Philadelphia to discuss a breakthrough treatment

    Cooper offers a world-first test of newly approved melanoma therapy to be made i

    A South Jersey woman was the first in the world to receive the therapy as her first treatment for advanced melanoma. The therapy eventually will be made in Phil

    MD Anderson Cooper - Phase 3 Randomized Trial Utilizing TIL Therapy

    MD Anderson at Cooper first to enroll patients in Phase 3 Randomized Clinical Trial Utilizing TIL Therapy plus Pembrolizumab versus Pembrolizumab alone

    TIL Therapy

    In recent years, significant strides have been made in the field of cancer treatment. One such breakthrough is tumor-infiltrating lymphocyte therapy, also known

    Young Ki Hong, MD: Helping Patients Fight Cancer Head On

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Complex General Surgical Oncology, 2016 - 2018
  • University of Louisville School of Medicine
    University of Louisville School of MedicineFellowship, Hepatopancreatobiliary Surgery, 2016 - 2018
  • University of Louisville
    University of LouisvilleMPH, Health Policy, 2016 - 2018
  • MedStar Health Georgetown University (D.C.)
    MedStar Health Georgetown University (D.C.)Residency, Surgery, 2013 - 2016
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Complex General Surgical Oncology, 2011 - 2013

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2018 - 2027
  • KY State Medical License
    KY State Medical License 2016 - 2019
  • VA State Medical License
    VA State Medical License 2012 - 2018
  • DC State Medical License
    DC State Medical License 2013 - 2016
  • MD State Medical License
    MD State Medical License 2010 - 2014
  • Surgery
    American Board of Surgery Surgery
  • Complex General Surgical Oncology
    American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • NJ Biz Health Care Heroes 2024 - Innovation Hero NJ Biz Magazine, 2024
  • Jeffrey and Joan Matthews Developing Leaders Program The Society for Surgery of Alimentary Tract, 2024
  • Resident Manuscript Competition (Dr. Rebecca Platoff) - Epigenetic Dysregulation Correlates with Oncotype Dx Score: Activation of Immune Pathways as a Novel Implication for Adjuvant Therapy in Breast New Jersey Chapter of American College of Surgeons, 2023

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Personalizing Locoregional Therapy for Patients with Metastatic Colorectal Cancer  
    Hong Y, Martin R, II, Curr Colorectal Cancer Rep
  • Blockchain and non-fungible tokens (NFTs) in surgery: hype or hope?  
    Batchu S, Henry OS, Patel K, Hakim A, Atabek U, Spitz F, Hong Y, Surgery in Practice and Science

Books/Book Chapters

  • Passing the General Surgery Oral Board Exam 
    Chapter: Chapter 50 Gallstone Ileus 
    Keshav Kooragayala, Young HongEditors: Marc Neff.Springer Nature
  • Passing the General Surgery Oral Board Exam 
    Chapter: Ch 51 Choledochal Cyst 
    Keshav Kooragayala, Young HongEditors: Marc Neff.Springer Nature
  • Passing the General Surgery Oral Board Exam 
    Chapter: Ch 52 Choledocholithiasis 
    Keshav Kooragayala, Young HongEditors: Marc Neff.Springer Nature

Abstracts/Posters

  • TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs. pembro alone in treatment-naive u...
    Young Hong, Daniel Olson, James Larkin, Sajeve Thomas, Juan Martin-Liberal, Andrew Furness, Patrick Terheyden, Gino In, Andrew Poklepovic, Yazan Samhouri, Philip Lamme..., Society for Melanoma Research (SMR), Philadelphia, PA, 11/6/2023
  • Trial in Progress: A Phase 3 study (TILVANCE-301) to assess the efficacy and safety of lifileucel, an autologous tumor-infiltrating lymphocyte cell therapy, in combina...
    James Larkin, Young Hong, Sajeve Thomas, Juan Martin-Liberal, Andrew Furness, Patrick Terheyden, Friedrich Finckenstein, Xiao Wu, Giri Sulur, Wen Shi, Daniel Olson., American Society of Clinical Oncology (ASCO), Chicago, IL, 6/2/2023
  • Novel Epigenetic Therapy For Hyperthermal Intraperitoneal Chemotherapy Enables Gene Remodeling of the Tumor Microenvironment
    Coburn-Flynn O, Butchy M, Calendo G, Emery R, Vercchio V, Knapp K, Ladd Z, Spitz F, Zhang P, Jelinek J, Hong Y, Society for Surgery of Alimentary Tract, Chicago, IL, 5/7/2023

Lectures

  • HIPEC Program at Cooper 
    Dept. of Anesthesiology Grand Rounds, Cooper University Hospital - 11/21/2023
  • Immunotherapy: Success, Challenges, and Novel Strategies 
    Coriell Institute for Medical Research - 9/24/2019
  • Immunotherapy: Success, Challenges, and Novel Strategies 
    Dept. of Surgery Grand Rounds, Cooper University Hospital - 1/15/2019

Press Mentions

  • South Korea doctor crisis: Urgent lessons for U.S. healthcare
    South Korea doctor crisis: Urgent lessons for U.S. healthcareMay 9th, 2025
  • South Korea’s Physician Shortage Crisis: Lessons For US Policy Makers
    South Korea’s Physician Shortage Crisis: Lessons For US Policy MakersApril 29th, 2025
  • South Korea’s Physician Shortage Crisis: Lessons For US Policy Makers
    South Korea’s Physician Shortage Crisis: Lessons For US Policy MakersApril 29th, 2025

Grant Support

  • Cooper Foundation GrantCooper Foundation/MD Anderson Cooper2018–2024

Committees

  • Vice-Chair Program Committee, American College of Surgeons 2025 - Present
  • Program Committee - Member, Society of Asian Academic Surgeons 2025 - Present
  • Editorial Board, The American Surgeon 2024 - Present
  • Chair of Education - Young Fellows Association Governing Council, American College of Surgeons 2024 - Present
  • Complex General Surgical Oncology EPA Workgroup, American Board of Surgery 2024 - Present

Research History

  • Director of Cellular TherapyPrincipal Investigator and Director of Autologous Tumor Infiltrating Lymphocytes (TIL) Therapy for Metastatic Melanoma, Non-Small Cell Lung Cancer, and Head & Neck2023 - Present
  • Director of Clinical Research2023 - Present
  • Principal InvestigatorHuman-to-Mouse Cancer Tumor Grafts for Personalized Cancer Medicine2023 - Present
  • Director, Surgical Outcomes Research GroupWeekly surgical outcomes group with fellow medical students, residents, faculty surgeons and collaborators to focus on surgical outcomes projects. Serve as a research mentor for medical students and residents with various projects.2018 - Present
  • Principal InvestigatorOur lab focuses on immunomodulation in hepatopancreatobiliary malignancies by elucidating epigenetic dysregulation.2018 - Present

Professional Memberships

Other Languages

  • Korean

Industry Relationships

  • Consultant, Histosonics2025 - Present
  • Scientific Advisory Board, Made Scientific2025 - Present
  • Consultant, Dilon2024 - Present
  • Consultant, Castle Biosciences2024 - Present
  • Consultant, Johnson and Johnson2024 - Present

External Links

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Young Hong, Dr. Young Hong, MD, Dr. Y Hong, Dr. Young Ki Hong